Lintbells, a renowned pet supplement manufacturer, has issued a warning to consumers about counterfeit versions of their celebrated products surfacing in the market. This situation poses significant ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended ...

The Agriculture and Horticulture Development Board has issued a vital alert to UK cattle farmers regarding a growing risk of lungworm infections. Due to prevailing weather conditions, the potential ...

BioNTech has reported a downturn in its COVID-19 vaccine sales for the third quarter of 2023, prompting the company to readjust its annual sales forecast. This unexpected decline contrasts with ...

bioAffinity, a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today announced that William Bauta, Ph.D., has been ...

As a Marketing professional, we help you join growing businesses who work across OTC, Generics, FMCG, Technological, Automation and Robotics. We have relationships with employers who positively impact ...

H. Lundbeck A/S (Lundbeck) announced that Vyepti® (eptinezumab) met the primary and all key secondary endpoints in SUNRISE, a phase III pivotal clinical trial predominantly conducted in Asia ...

Staad, 30 October 2024– Biosynth, a leading developer and supplier of critical raw materials and services for diagnostics, vaccines, and pharmaceutical industries, is pleased to announce the opening ...

bioAffinity Technologies, a biotechnology company focused on the need for noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today announced that the Japan Patent ...

“After more than a decade of underinvestment and short-termism, we welcome the Chancellor’s commitment to a long-term approach to rebuilding the NHS and other public services. “The additional ...

Pharmaceutical giant Merck, known as MSD, has finalised a substantial acquisition of Modifi Biosciences, a spinout from Yale University, in a deal that could be worth up to $1.3 billion. This move ...